{"nct_id":"NCT01765426","title":"Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2013-02-15","start_date_type":"ACTUAL","primary_completion_date":"2014-06-26","primary_completion_date_type":"ACTUAL","completion_date":"2014-06-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}